Top Markets
Coin of the day
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
株式のランク #24450
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
株価
$0.78611575
時価総額
$60.45M
変化(1日)
0.00%
変化(1年)
-12.06%
NO
取引 Lytix Biopharma AS (LYTIX)

カテゴリー

Lytix Biopharma AS(LYTIX)の株価履歴
終値の最高値: $0.83 (2026-08-01)

終値の最安値: $1.84 (2021-06-01)
Lytix Biopharma AS の株価履歴(2021 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -4.78%
2025 65.95%
2024 18.94%
2023 -38.40%
2022 -48.20%
2021 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$546.40 37.47%
US
$1.05K 57.85%
NL
$118.70 -18.24%
AU
$140.43 435.58%
US
$770.19 9.84%
CH